Efficacy and Tolerability of the Carboplatin, Paclitaxel, Cetuximab (CTE) Regimen for Head and Neck Squamous Cell Carcinomas

Presenter Information

M. Locke MD

Facility

NS/LIJ

Department

Department of Medicine

Status

Resident

Category

Clinical Science Research

Start Date

1-6-2022 12:00 AM